Paul Fonteyne
Paul Fonteyne has the role of Executive in Residence at Canaan Partners.
Contact
- Social accounts: linkedin
Companies
Company
Roles
Gelesis
A biotechnology company developing treatments for obesity and diabetes
Board Member
Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biotechnology research company developing drug delivery technologies and therapeutics for the treatment of chronic inflammatory diseases.
Board Member
Amylyx Pharmaceutical
Amylyx Pharmaceutical is a combination of existing products founded in 2013 by Justin Klee.
Board Member